134 related articles for article (PubMed ID: 17108870)
21. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
22. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
23. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
[TBL] [Abstract][Full Text] [Related]
24. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
Braeuning A; Menzel M; Kleinschnitz EM; Harada N; Tamai Y; Köhle C; Buchmann A; Schwarz M
FEBS J; 2007 Sep; 274(18):4766-77. PubMed ID: 17697114
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
26. [Laminin and its alpha 6 integrin receptor in the regulation of human hepatocellular carcinoma cell phenotypes].
Lu TJ; Zhang QY; Zhou RL
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):31-5. PubMed ID: 12678983
[TBL] [Abstract][Full Text] [Related]
27. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
[TBL] [Abstract][Full Text] [Related]
28. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
29. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
30. Effect of phorbol 12-myristate-13-acetate on cell adhesion in SMMC-7721 human hepatocellular carcinoma cell line and its mechanism.
Fu JZ; Zha XL
J Exp Clin Cancer Res; 1998 Jun; 17(2):153-7. PubMed ID: 9700575
[TBL] [Abstract][Full Text] [Related]
31. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
32. Role and significance of focal adhesion proteins in hepatocellular carcinoma.
Yam JW; Tse EY; Ng IO
J Gastroenterol Hepatol; 2009 Apr; 24(4):520-30. PubMed ID: 19368632
[TBL] [Abstract][Full Text] [Related]
33. Rho GTPase and Wnt signaling pathways in hepatocarcinogenesis.
Lechel A; Rudolph KL
Gastroenterology; 2008 Mar; 134(3):875-8. PubMed ID: 18325396
[No Abstract] [Full Text] [Related]
34. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
35. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
36. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow cells: the source of hepatocellular carcinoma?
Wu XZ; Yu XH
Med Hypotheses; 2007; 69(1):36-42. PubMed ID: 17300877
[TBL] [Abstract][Full Text] [Related]
38. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition.
Imamichi Y; Menke A
Cells Tissues Organs; 2007; 185(1-3):180-90. PubMed ID: 17587824
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
40. [Partial reversion of the phenotype of a poorly differentiated hepatocellular carcinoma in a three-dimensional culture].
Rudinskaia TD; Kuprina NI; Lazarevich NL; Polianskaia NI; Poltoranina VS; Shavochkina DA; Engel'gardt NV
Ontogenez; 2010; 41(1):58-65. PubMed ID: 20184122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
